XML 20 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 24, 2022
Sep. 25, 2021
Sep. 24, 2022
Sep. 25, 2021
Revenues:        
Total revenues $ 11,729,379 $ 10,887,173 $ 35,216,833 $ 32,468,797
Expenses:        
Cost of product revenues 7,987,154 5,145,175 23,676,283 17,586,389
Research and development 3,441,405 3,751,729 13,995,393 11,055,282
Selling, general and administration 4,320,117 4,035,998 13,112,133 13,982,682
Total expenses 15,748,676 12,932,902 50,783,809 42,624,353
Loss from operations (4,019,297) (2,045,729) (15,566,976) (10,155,556)
Other (expense) income        
Interest income 21,663 9,959 41,195 22,244
Other expense, net (3,225) (31,529) (7,952) (33,574)
(Loss) gain on investments (2,000,000) 2,700,000
Foreign currency transaction (losses) gains (112,315) (29,384) (227,294) 100,597
Total other (expense) income (2,093,877) (50,954) 2,505,949 89,267
Loss before provision for income taxes and net loss attributable to noncontrolling interest (6,113,174) (2,096,683) (13,061,027) (10,066,289)
Tax provision (36,000) (32,000) (108,000) (97,000)
Net loss (6,149,174) (2,128,683) (13,169,027) (10,163,289)
Net (income) loss attributable to the noncontrolling interest (107) 280 39,394
Net loss attributable to Kopin Corporation $ (6,149,174) $ (2,128,790) $ (13,168,747) $ (10,123,895)
Net loss per share        
Basic and diluted $ (0.07) $ (0.02) $ (0.14) $ (0.11)
Weighted average number of common shares outstanding        
Basic and diluted 93,516,231 90,517,330 91,317,288 88,903,658
Net Product Revenues [Member]        
Revenues:        
Total revenues $ 8,254,686 $ 6,591,852 $ 23,765,872 $ 21,089,515
Research and Development and Other Revenues [Member]        
Revenues:        
Total revenues $ 3,474,693 $ 4,295,321 $ 11,450,961 $ 11,379,282